Company Monitoring Page for Janssen

latest headlines for company on cafepharma

J&J Will Appeal $8 Billion Verdict of Claims Risperdal Caused Breast Growth
BioSpace
Thu, 10/10/19 - 09:41 am
Tags:
JNJ, Janssen, Risperdal
J&J adds 200 jobs with new biopharma plant at site in Ireland
Fierce Pharma
Mon, 10/7/19 - 11:14 pm
Tags:
JNJ, Janssen, Ireland, drug manufacturing, hirings
Johnson & Johnson commits $500 million over four years to help end HIV, TB epidemics
Marketwatch
Fri, 10/4/19 - 10:29 am
Tags:
JNJ, Janssen, tuberculosis, HIV, philanthropy
Updated Erleada Data Shows Reduced Risk of Death in Prostate Cancer Patients
BioSpace
Sat, 09/28/19 - 04:25 pm
Tags:
Erleada, Janssen, JNJ, ESMO, prostate cancer
Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO
Fierce Biotech
Mon, 09/23/19 - 10:43 am
Tags:
gene therapy, Passage Bio, Janssen
Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed
Drug Channels
Tue, 09/17/19 - 03:35 pm
Tags:
Eli Lilly, Janssen, Merck, Novartis, Sanofi, drug pricing
Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial
Pharmaforum
Thu, 09/12/19 - 10:28 am
Tags:
JNJ, Janssen, ponesimod, Sanofi, Aubagio, relapsing multiple sclerosis
J&J gets Stelara okay in Europe for ulcerative colitis
Pharmaforum
Fri, 09/6/19 - 08:35 pm
Tags:
JNJ, Stelara, Janssen, Europe
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
Tags:
drug pricing, Canada, Janssen, Merck, Bayer, Servier, Boehringer Ingelheim
Janssen gets EC approval for two new indications of Imbruvica
Pharmaceutical Business Review
Wed, 08/14/19 - 10:17 am
Tags:
JNJ, Janssen, Europe, Imbruvica, Waldenström’s macroglobulinemia, chronic lymphocytic leukemia
Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%
Pharmaceutical Business Review
Fri, 08/2/19 - 11:48 pm
Tags:
Janssen, Alligator Biosciences, CD40, cancer immunotherapy
Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial
BioSpace
Fri, 07/26/19 - 10:59 am
Tags:
Janssen, JNJ, ponesimod, Sanofi, Aubagio, relapsing multiple sclerosis
FDA quickly approves J&J’s Darzalex in multiple myeloma
Pharmaforum
Fri, 06/28/19 - 12:32 pm
Tags:
JNJ, Janssen, FDA, Darzalex, Multiple Myeloma
Time to fix pharma’s outdated business model
Pharmaforum
Sat, 06/22/19 - 12:33 pm
Tags:
pharma industry, payers, patients, Janssen
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
Tue, 06/18/19 - 11:38 pm
Tags:
JNJ, Janssen, Tremfya, clinical trials, psoriatic arthritis
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
Fri, 06/14/19 - 06:23 pm
Tags:
JNJ, Janssen, clinical trials, Tremfya, psoriatic arthritis
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
KHN
Tue, 06/11/19 - 11:41 pm
Tags:
FDA, Janssen, Spravato, esketamine, major depressive disorder
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
BioSpace
Mon, 06/10/19 - 06:05 pm
Tags:
Janssen, clinical trials, patients
Janssen inks nference AI research pact
Fierce Biotech
Mon, 06/10/19 - 09:47 am
Tags:
JNJ, Janssen, R&D, artificial intelligence, nference
J&J passes key milestone in HIV vaccine trial
Pharmaforum
Thu, 05/30/19 - 09:40 am
Tags:
JNJ, Janssen, clinical trials, vaccines, HIV, Imbokodo

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.